+ Reply to Thread
Results 1 to 10 of 2095

Thread: Replicel

Hybrid View

  1. #1
    Senior Member
    Join Date
    Mar 2010
    Location
    UK
    Posts
    218

    Default

    ...nobody's started to hold their breath yet right?

  2. #2
    Senior Member
    Join Date
    Aug 2011
    Posts
    102

    Default

    Quote Originally Posted by 57mph View Post
    ...nobody's started to hold their breath yet right?
    Nah I think we all know that the next generation of treatments won't come any earlier than 2013/2014

  3. #3
    Senior Member
    Join Date
    Mar 2011
    Posts
    1,105

    Default

    Quote Originally Posted by uninformed View Post
    Nah I think we all know that the next generation of treatments won't come any earlier than 2013/2014
    I think you're probably right...

  4. #4
    Member
    Join Date
    Jan 2011
    Location
    UK
    Posts
    64

    Default

    Just received this email update, it seems they have dropped a test participant to keep to their desired time frame:

    VANCOUVER, BC – September 7, 2011 - RepliCel Life Sciences Inc. is pleased to report that the final study participant has received injections of hair follicle cells prepared using RepliCel™ technology. This milestone marks the end of the treatment phase of the TS001-2009 clinical trial in which a total of nineteen participants received injections. To date, no serious adverse events have been reported post-injection. Please note that recruitment of subjects was closed at nineteen (rather than the planned twenty) to allow for timely processing of interim analysis data from the six-month follow-up time point. This interim analysis is scheduled to take place in Q1, 2012.

  5. #5
    Member
    Join Date
    Jun 2011
    Posts
    57

    Default

    Quote Originally Posted by Zoidberg View Post
    Just received this email update, it seems they have dropped a test participant to keep to their desired time frame:

    VANCOUVER, BC – September 7, 2011 - RepliCel Life Sciences Inc. is pleased to report that the final study participant has received injections of hair follicle cells prepared using RepliCel™ technology. This milestone marks the end of the treatment phase of the TS001-2009 clinical trial in which a total of nineteen participants received injections. To date, no serious adverse events have been reported post-injection. Please note that recruitment of subjects was closed at nineteen (rather than the planned twenty) to allow for timely processing of interim analysis data from the six-month follow-up time point. This interim analysis is scheduled to take place in Q1, 2012.
    Wow I'm excited to see the results.

  6. #6
    Senior Member
    Join Date
    Jul 2011
    Location
    agaexperts.meteor.com
    Posts
    1,405

    Default

    Quote Originally Posted by Zoidberg View Post
    Just received this email update, it seems they have dropped a test participant to keep to their desired time frame:

    VANCOUVER, BC – September 7, 2011 - RepliCel Life Sciences Inc. is pleased to report that the final study participant has received injections of hair follicle cells prepared using RepliCel™ technology. This milestone marks the end of the treatment phase of the TS001-2009 clinical trial in which a total of nineteen participants received injections. To date, no serious adverse events have been reported post-injection. Please note that recruitment of subjects was closed at nineteen (rather than the planned twenty) to allow for timely processing of interim analysis data from the six-month follow-up time point. This interim analysis is scheduled to take place in Q1, 2012.


    god help them help me

Tags for this Thread

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts

» IAHRS

hair transplant surgeons

» The Bald Truth